JASPER THERAPEUTICS, INC. Stock Redeemed or Called During Period, Value
JASPER THERAPEUTICS, INC. (JSPR) reported Stock Redeemed or Called During Period, Value of -$3.57 million for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-16.
Discontinued › Shareholders' Equity
us-gaap:StockRedeemedOrCalledDuringPeriodValue · last filed 2021-08-16
- JASPER THERAPEUTICS, INC. stock redeemed or called during period, value for the quarter ending 2021-06-30 was -$3.57M.
- JASPER THERAPEUTICS, INC. stock redeemed or called during period, value for the quarter ending 2021-03-31 was $5.50M, a 284.79% increase year-over-year.
- JASPER THERAPEUTICS, INC. stock redeemed or called during period, value for the quarter ending 2020-06-30 was -$3.43M.
- JASPER THERAPEUTICS, INC. stock redeemed or called during period, value for the quarter ending 2020-03-31 was $1.43M.
| Period end | Stock Redeemed or Called During Period, Value 3 month | Stock Redeemed or Called During Period, Value 3 month as first filed | Stock Redeemed or Called During Period, Value 5 month | Stock Redeemed or Called During Period, Value 5 month as first filed | Stock Redeemed or Called During Period, Value 6 month |
|---|---|---|---|---|---|
| 2021-06-30 | -$3.57M 10-Q · filed 2021-08-16 | $1.93M derived: sum of 2 quarters · filed 2021-08-16 | |||
| 2021-03-31 | $5.50M 10-Q · filed 2021-08-16 | -$5.50M 10-Q · filed 2021-05-24 | |||
| 2020-06-30 | -$3.43M 10-Q · filed 2021-08-16 | -$2.00M derived: sum of 2 quarters · filed 2021-08-16 | |||
| 2020-03-31 | $1.43M 10-Q · filed 2021-08-16 | -$1.43M 10-Q · filed 2021-05-24 | |||
| 2019-12-31 | $85.84M 10-K/A · filed 2021-05-24 | $93.08M 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |